Salazopyrin out of stock until June 1

The Pharmaceutical Services Negotiating Committee has informed community pharmacies that Salazopyrin (sulfasalazine) 500mg suppositories are out of stock until the week beginning June 1.

The negotiator said supply issues affecting the medication, which is used to treat rheumatoid arthritis, ulcerative colitis and Crohn's disease, were caused by “an increase in demand seen by the sole supplier Pfizer.” 

PSNC also reported that limited supplies of Salofalk (mesalazine) 500mg suppositories, used to treat inflammatory bowel disease including ulcerative colitis and Crohn's disease, will be available from Monday May 18 and that Pentasa 1g suppositories remain available during this period.

Comments (0)

This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Pharmacy Network News's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.